Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 16, keine Gesamtzahl für „section“
Suchtreffer
Begriffe & Kennungen
Blincyto · 4.8 · For clinical management of elevated liver enzymes, see section 4.4.
Eintrag öffnenBlincyto · 4.8 · For clinical management of infections, see section 4.4.
Eintrag öffnenBlincyto · 4.8 · For clinical management of neurologic events and ICANS, see section 4.2.
Eintrag öffnenBlincyto · 4.8 · The adverse reactions described in this section were identified in clinical studies of patients with B-cell pr
Eintrag öffnenBondronat · 4.3 · - Hypersensitivity to ibandronic acid or to any of the excipients listed in section 6.1. - Hypocalcaemia - Abn
Eintrag öffnenBondronat · 4.3 · - Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 - Hypocalcaemia
Eintrag öffnenBondronat · 4.3 · - Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 - Hypocalcaemia
Eintrag öffnenBonviva · 4.3 · - Hypersensitivity to ibandronic acid or to any of the excipients listed in section 6.1 - Hypocalcaemia
Eintrag öffnenBonviva · 4.3 · - Hypersensitivity to ibandronic acid or to any of the excipients listed in section 6.1 - Hypocalcaemia - Abno
Eintrag öffnenBortezomib Accord · 4.3 · Hypersensitivity to the active substance, to boron or to any of the excipients listed in section 6.1. Acute di
Eintrag öffnenBortezomib Accord · 4.3 · Hypersensitivity to the active substance, to boron or to any of the excipients listed in section 6.1. Acute di
Eintrag öffnenBortezomib Sun · 4.3 · Hypersensitivity to the active substance, to boron or to any of the excipients listed in section 6.1. Acute di
Eintrag öffnenBosulif · 4.3 · Hepatic impairment (see sections 5.1 and 5.2).
Eintrag öffnenBosulif · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenBraftovi · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenBretaris Genuair · 4.3 · Hypersensitivity to aclidinium bromide or to the excipients listed in section 6.1.
Eintrag öffnenBridion · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenBridion · 4.5 · The information in this section is based on binding affinity between sugammadex and other medicinal products,
Eintrag öffnenBrilique · 4.3 · • Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 (see section 4.8)
Eintrag öffnenBrilique · 4.3 · • Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 (see section 4.8)
Eintrag öffnen